Compound Detail
CHEMBL401989
ERASTIN Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O
Basic Information
| ChEMBL ID | CHEMBL401989 |
| Name | ERASTIN |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BKQFRNYHFIQEKN-UHFFFAOYSA-N |
24
Targets
49
Activities
3
Assay Types
3
PK Parameters
20
Publications
0
Known Names
Molecular Properties
547.1
MW (Da)
4.72
ALogP
7
HBA
0
HBD
76.9
PSA (Ų)
0.32
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 25 meas. best 6.85
EC50 23 meas. best 6.22
Kd 1 meas. best 7.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-dependent anion-selective channel protein 2 CHEMBL6190 | Kd | 7.0 | 7.0 | 100.0 | 1 |
| Cystine/glutamate transporter CHEMBL1075149 | IC50 | 6.85 | 6.75 | 140.0 | 3 |
| Calu-1 CHEMBL613505 | IC50 | 6.85 | 6.125 | 140.0 | 2 |
| HT-1080 CHEMBL614580 | IC50 | 6.7 | 5.8143 | 200.0 | 7 |
| Hepa 1-6 CHEMBL6066745 | IC50 | 6.3 | 6.3 | 500.0 | 1 |
| MC-38 CHEMBL612821 | IC50 | 6.3 | 6.3 | 500.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.3 | 6.25 | 500.0 | 2 |
| HeLa CHEMBL399 | EC50 | 6.22 | 6.22 | 600.0 | 1 |
| C-33-A CHEMBL2366313 | EC50 | 6.22 | 6.22 | 600.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.2 | 6.2 | 625.0 | 1 |
| BJ CHEMBL614358 | IC50 | 6.05 | 5.578 | 900.0 | 5 |
| ID8 CHEMBL6066801 | IC50 | 5.92 | 5.92 | 1200.0 | 1 |
| HT-1080 CHEMBL614580 | EC50 | 5.7 | 5.7 | 2000.0 | 1 |
| SVR CHEMBL614869 | EC50 | 5.6 | 5.6 | 2500.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 5.52 | 5.0575 | 3000.0 | 8 |
| B16 CHEMBL381 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| SK-LMS-1 CHEMBL2366096 | EC50 | 5.22 | 5.22 | 6000.0 | 1 |
| U2OS CHEMBL615023 | EC50 | 5.22 | 5.22 | 6000.0 | 1 |
| BJ CHEMBL614358 | EC50 | 5.22 | 5.11 | 6000.0 | 2 |
| LNCaP CHEMBL612518 | EC50 | 5.22 | 5.22 | 6000.0 | 1 |
| SK-ES1 CHEMBL613970 | EC50 | 5.16 | 5.16 | 7000.0 | 1 |
| SK-N-MC CHEMBL614163 | EC50 | 5.0 | 5.0 | 10000.0 | 1 |
| U-937 CHEMBL612794 | EC50 | 5.0 | 5.0 | 10000.0 | 1 |
| SJSA-1 CHEMBL2366298 | EC50 | 4.92 | 4.92 | 12000.0 | 1 |
| HOS CHEMBL614736 | EC50 | 4.77 | 4.77 | 17000.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 4.68 | 4.68 | 20890.0 | 1 |
| A673 CHEMBL614517 | EC50 | 4.52 | 4.52 | 30000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 0.08333 | hr | Mus musculus |
| T1/2 | 0.06667 | hr | Homo sapiens |
| T1/2 | 0.05833 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17568748 | 10.1038/nature05859 | BJ | 21 |
| 17568748 | 10.1038/nature05859 | NON-PROTEIN TARGET | 17 |
| 17568748 | 10.1038/nature05859 | HT-1080 | 12 |
| 17568748 | 10.1038/nature05859 | Mitogen-activated protein kinase; ERK1/ERK2 | 12 |
| 35282680 | 10.1021/acs.jmedchem.1c01775 | A549 | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 17568748 | 10.1038/nature05859 | A673 | 4 |
| 17568748 | 10.1038/nature05859 | HeLa | 4 |
| 36410168 | 10.1016/j.ejmech.2022.114905 | ADMET | 4 |
| 39145486 | 10.1021/acs.jmedchem.4c00729 | PC-9 | 3 |
| 22832321 | 10.1016/j.bmcl.2012.06.077 | NON-PROTEIN TARGET | 3 |
| 26231156 | 10.1016/j.bmcl.2015.07.018 | NON-PROTEIN TARGET | 3 |
| 22832321 | 10.1016/j.bmcl.2012.06.077 | Unchecked | 2 |
| 17568748 | 10.1038/nature05859 | LNCaP | 2 |
| 17568748 | 10.1038/nature05859 | SK-LMS-1 | 2 |
| 17568748 | 10.1038/nature05859 | SJSA-1 | 2 |
| 17568748 | 10.1038/nature05859 | HOS | 2 |
| 17568748 | 10.1038/nature05859 | U-937 | 2 |
| 17568748 | 10.1038/nature05859 | SK-N-MC | 2 |
| 30522056 | 10.1016/j.ejmech.2018.11.066 | Cystine/glutamate transporter | 2 |
Data from ChEMBL 36 via Core Engine